FDA-approved CAR T-cell Therapy: A Decade of Progress and Challenges.

导出 LinkOut

翻译打印收藏纠错

作者： Melissa Z,Ong ^[1] ; Sharon A,Kimberly ^[1] ; Wen-Hwei,Lee ^[1] ; Marcus,Ling ^[1] ; Michael,Lee ^[1] ; Ke-Wei,Tan ^[1] ; Jhi-Biau,Foo ^[2] ; Hui-Yin,Yow ^[3] ; Renukha,Sellappans ^[1] ; Sharina,Hamzah ^[2]

作者单位： School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, 47500, Subang Jaya, Selangor, Malaysia. ^[1] School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, 47500, Subang Jaya, Selangor, Malaysia.;Medical Advancement for Better Quality of Life Impact Lab, Taylor's University, 47500, Subang Jaya, Selangor, Malaysia. ^[2] Department of Pharmaceutical Life Sciences, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia. ^[3]

关键词 CAR T-cell T-cell cancer therapy clinical application.gene therapy immunotherapy

主题词人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);肿瘤(Neoplasms);美国食品和药物管理局(United States Food and Drug Administration);美国(United States);T淋巴细胞(T-Lymphocytes);动物(Animals)

DOI 10.2174/0113892010257212231001082741

PMID 39034731

发布时间 2024-08-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交